These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8102211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
    Dang J, Wang Y, Doe WF.
    FEBS Lett; 1995 Feb 13; 359(2-3):147-50. PubMed ID: 7867787
    [Abstract] [Full Text] [Related]

  • 5. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 13; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 6. The plasminogen-activating system in hepatic stellate cells.
    Leyland H, Gentry J, Arthur MJ, Benyon RC.
    Hepatology; 1996 Nov 13; 24(5):1172-8. PubMed ID: 8903394
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec 13; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 8. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Illemann M, Bird N, Majeed A, Laerum OD, Lund LR, Danø K, Nielsen BS.
    Int J Cancer; 2009 Apr 15; 124(8):1860-70. PubMed ID: 19123477
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM, Stark HJ, Fusenig NE, Todd RF, Kramer MD.
    Exp Cell Res; 1995 Oct 15; 220(2):415-23. PubMed ID: 7556451
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 15; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.
    J Hepatol; 1999 Oct 15; 31(4):703-11. PubMed ID: 10551395
    [Abstract] [Full Text] [Related]

  • 15. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ.
    Cancer Res; 2000 Oct 15; 60(20):5839-47. PubMed ID: 11059781
    [Abstract] [Full Text] [Related]

  • 16. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
    Lund LR.
    FEBS Lett; 1996 Apr 01; 383(3):139-44. PubMed ID: 8925884
    [Abstract] [Full Text] [Related]

  • 17. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.
    Cancer Res; 2007 Jan 01; 67(1):9-15. PubMed ID: 17210677
    [Abstract] [Full Text] [Related]

  • 18. Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1).
    Borgfeldt C, Hansson SR, Gustavsson B, Måsbäck A, Casslén B.
    Int J Cancer; 2001 May 15; 92(4):497-502. PubMed ID: 11304683
    [Abstract] [Full Text] [Related]

  • 19. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
    Gyetko MR, Shollenberger SB, Sitrin RG.
    J Leukoc Biol; 1992 Mar 15; 51(3):256-63. PubMed ID: 1311745
    [Abstract] [Full Text] [Related]

  • 20. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T, Blasi F, Talarico D.
    Dev Dyn; 1998 Sep 15; 213(1):27-38. PubMed ID: 9733098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.